Literature DB >> 22101672

Isolated navicular-medial cuneiform tarsal coalition revisited: a case report.

James R Ross1, Matthew B Dobbs.   

Abstract

Tarsal coalitions between the navicular and the cuneiforms occur infrequently when compared with the more common talocalcaneal and calcaneonavicular coalitions. Isolated cases of navicular-medial cuneiform coalitions have only rarely been reported; however, the diagnosis is likely underrecognized. Conservative management should be pursued initially for symptomatic patients, followed by surgical options for unresponsive cases. The few reports available recommend treatment with navicular-medial cuneiform fusions, but long-term follow-up is not available to assess outcome and it remains unclear whether an isolated arthrodesis of the navicular-medial cuneiform joint will in turn lead to differing biomechanics of adjacent joints. We report a case of a patient with an isolated navicular-medial cuneiform coalition, treated with resection and free-fat interposition rather than arthrodesis. To our knowledge, this is the first case of a navicular-medial cuneiform coalition reported in a patient of North American ancestry. At 2 years postoperatively, she is pain-free with all activities and has full range of motion of her ankle and subtalar joints, and full mobility at the navicular-medial cuneiform joint. This unique method provided a successful solution to this difficult situation.

Entities:  

Mesh:

Year:  2011        PMID: 22101672     DOI: 10.1097/BPO.0b013e31822cd47f

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  2 in total

1.  Talocalcaneal coalition: A focus on radiographic findings and sites of bridging.

Authors:  Soon Hyuck Lee; Hyung Jun Park; Eui Dong Yeo; Young Koo Lee
Journal:  Indian J Orthop       Date:  2016 Nov-Dec       Impact factor: 1.251

Review 2.  Treatment of isolated talonavicular coalition: Case report and literature review.

Authors:  Xiaojun Duan; Liu Yang
Journal:  J Int Med Res       Date:  2018-11-19       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.